News

Quotient's VP of Drug Development Sciences, Dr Sarah Stevens, discusses our recent acquisition of Arcinova and the integration of drug substance, drug product, and clinical testing capabilities – all under one or­ganization, in Drug Development & Delivery's Special Feature Report

Content: Quotient has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards. The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development arena. Quotient received leadership awards in five of the overall six categories.

Quotient Sciences was featured in Drug Development & Delivery's Special Feature article entitled: "Improving Bioavailability & Solubility: Each Molecule Is Unique."

Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.

Arcinova, a Quotient Sciences business, announces major investment in Alnwick site with the installation of the R1000 capsule fill machine from 3P Innovation

Exciting news - Arcinova, a Quotient Sciences business, has won the CPhI Pharma Award for Excellence in Pharma: Contract Services & Oursourcing for our Flowinova Project